56 related articles for article (PubMed ID: 8380695)
1. Prior arterial injury enhances luciferase expression following in vivo gene transfer.
Barbee RW; Stapleton DD; Perry BD; Ré RN; Murgo JP; Valentino VA; Cook JL
Biochem Biophys Res Commun; 1993 Jan; 190(1):70-8. PubMed ID: 8380695
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of luciferase activity of viral and hybrid promoters in bovine preimplantation embryos.
Nakamura A; Okumura J; Muramatsu T
Mol Reprod Dev; 1998 Apr; 49(4):368-73. PubMed ID: 9508087
[TBL] [Abstract][Full Text] [Related]
3. Lipofectin-mediated versus adenovirus-mediated gene transfer in vitro and in vivo: comparison of canine and porcine model systems.
Mazur W; Ali NM; Grinstead WC; Schulz DG; Raizner AE; French BA
Coron Artery Dis; 1994 Sep; 5(9):779-86. PubMed ID: 7858769
[TBL] [Abstract][Full Text] [Related]
4. A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo.
Nitta Y; Kawamoto S; Halbert C; Iwata A; Miller AD; Miyazaki J; Allen MD
J Gene Med; 2005 Oct; 7(10):1348-55. PubMed ID: 15945122
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements.
Suzuki M; Singh RN; Crystal RG
Hepatology; 1998 Jan; 27(1):160-5. PubMed ID: 9425932
[TBL] [Abstract][Full Text] [Related]
6. [Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury].
Stephan D; San H; Gordon D; Nabel GJ; Nabel EG
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1121-5. PubMed ID: 9404420
[TBL] [Abstract][Full Text] [Related]
7. Design of a muscle cell-specific expression vector utilising human vascular smooth muscle alpha-actin regulatory elements.
Keogh MC; Chen D; Schmitt JF; Dennehy U; Kakkar VV; Lemoine NR
Gene Ther; 1999 Apr; 6(4):616-28. PubMed ID: 10476221
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
[TBL] [Abstract][Full Text] [Related]
9. Transgene expression in the coronary circulation: transcatheter gene delivery.
Shi Y; Fard A; Vermani P; Zalewski A
Gene Ther; 1994 Nov; 1(6):408-14. PubMed ID: 7584107
[TBL] [Abstract][Full Text] [Related]
10. Ischemic/reperfused myocardium can express recombinant protein following direct DNA or retroviral injection.
Prentice H; Kloner RA; Li Y; Newman L; Kedes L
J Mol Cell Cardiol; 1996 Jan; 28(1):133-40. PubMed ID: 8745221
[TBL] [Abstract][Full Text] [Related]
11. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
[TBL] [Abstract][Full Text] [Related]
12. Hydrodynamic plasmid DNA gene therapy model in liver transplantation.
Tsoulfas G; Takahashi Y; Liu D; Yagnik G; Wu T; Murase N; Geller DA
J Surg Res; 2006 Oct; 135(2):242-9. PubMed ID: 16926028
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of liposome-mediated gene transfer into vascular tissue by replication deficient adenovirus.
Raja-Walia R; Webber J; Naftilan J; Chapman GD; Naftilan AJ
Gene Ther; 1995 Oct; 2(8):521-30. PubMed ID: 8593602
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity.
Kolyada AY; Savikovsky N; Madias NE
Biochem Biophys Res Commun; 1996 Mar; 220(3):600-5. PubMed ID: 8607810
[TBL] [Abstract][Full Text] [Related]
17. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
March KL; Sandusky G; Fan L
Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686
[TBL] [Abstract][Full Text] [Related]
18. Effect of the rabbit alphas1-casein gene distal enhancer on the expression of a reporter gene in vitro and in vivo.
Pantano T; Jolivet G; Prince S; Menck-Le Bourhis C; Maeder C; Viglietta C; Rival S; Houdebine LM
Biochem Biophys Res Commun; 2002 Jan; 290(1):53-61. PubMed ID: 11779132
[TBL] [Abstract][Full Text] [Related]
19. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells.
Strayer DS; Kondo R; Milano J; Duan LX
Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
